All Stories

  1. Time-resolved dual transcriptomics of Pseudomonas aeruginosa biofilm formation in cystic fibrosis
  2. Evaluating ligand docking methods for drugging protein–protein interfaces: insights from AlphaFold2 and molecular dynamics refinement
  3. Exploring the therapeutic potential of recombinant bovine β-defensins for antimicrobial and anti-inflammatory functions in sepsis management
  4. Mining the heparinome for cryptic antimicrobial peptides that selectively kill Gram-negative bacteria
  5. Targeting MarA N‐terminal domain dynamics to prevent DNA binding
  6. The limits of prediction: Why intrinsically disordered regions challenge our understanding of antimicrobial peptides
  7. The battle within: how Pseudomonas aeruginosa uses host-pathogen interactions to infect the human lung
  8. From In Vitro Promise to In Vivo Reality: An Instructive Account of Infection Model Evaluation of Antimicrobial Peptides
  9. From In Vitro Promise to In Vivo Reality: An Instructive Account of Infection Model Evaluation of Antimicrobial Peptides
  10. PyAMPA: a high-throughput prediction and optimization tool for antimicrobial peptides
  11. The N-terminal helix of MarA as a key element in the mechanism of DNA binding
  12. Structural assembly of the bacterial essential interactome
  13. The C-Terminus of Panusin, a Lobster β-Defensin, Is Crucial for Optimal Antimicrobial Activity and Serum Stability
  14. The PRALINE database: protein and Rna humAn singLe nucleotIde variaNts in condEnsates
  15. Antimicrobial Peptides Can Generate Tolerance by Lag and Interfere with Antimicrobial Therapy
  16. Analysis of Host–Bacteria Protein Interactions Reveals Conserved Domains and Motifs That Mediate Fundamental Infection Pathways
  17. A high‐throughput approach to predict A‐to‐I effects on RNA structure indicates a change of double‐stranded content in noncoding RNAs
  18. Examining Topoisomers of a Snake-Venom-Derived Peptide for Improved Antimicrobial and Antitumoral Properties
  19. Essential Role of Enzymatic Activity in the Leishmanicidal Mechanism of the Eosinophil Cationic Protein (RNase 3)
  20. In Vivo Evaluation of ECP Peptide Analogues for the Treatment of Acinetobacter baumannii Infection
  21. HPIPred: Host–pathogen interactome prediction with phenotypic scoring
  22. Rationally Modified Antimicrobial Peptides from the N-Terminal Domain of Human RNase 3 Show Exceptional Serum Stability
  23. The Interplay Between Disordered Regions in RNAs and Proteins Modulates Interactions Within Stress Granules and Processing Bodies
  24. Time-Resolved Transcriptional Profiling of Epithelial Cells Infected by Intracellular Acinetobacter baumannii
  25. Bacteria use structural imperfect mimicry to hijack the host interactome
  26. Human RNase3 immune modulation by catalytic-dependent and independent modes in a macrophage-cell line infection model
  27. DualSeqDB: the host–pathogen dual RNA sequencing database for infection processes
  28. RNA-binding and prion domains: the Yin and Yang of phase separation
  29. BacFITBase: a database to assess the relevance of bacterial genes during host infection
  30. Insight into the Antifungal Mechanism of Action of Human RNase N-terminus Derived Peptides
  31. A Coordinated Response at The Transcriptome and Interactome Level is Required to Ensure Uropathogenic Escherichia coli Survival during Bacteremia
  32. The fitness cost and benefit of phase‐separated protein deposits
  33. Cells alter their tRNA abundance to selectively regulate protein synthesis during stress conditions
  34. Positional scanning library applied to the human eosinophil cationic protein/RNase3 N-terminus reveals novel and potent anti-biofilm peptides
  35. Structural similarities in the CPC clip motif explain peptide-binding promiscuity between glycosaminoglycans and lipopolysaccharides
  36. Centrality in the host–pathogen interactome is associated with pathogen fitness during infection
  37. Structural basis for endotoxin neutralization by the eosinophil cationic protein
  38. Biofilm erradication by eosinophil cationic protein
  39. Insights into the Antimicrobial Mechanism of Action of Human RNase6: Structural Determinants for Bacterial Cell Agglutination and Membrane Permeation
  40. Is membrane homeostasis the missing link between inflammation and neurodegenerative diseases?
  41. Prediction of Bioactive Peptides Using Artificial Neural Networks
  42. Ribonucleases as a host-defence family: evidence of evolutionarily conserved antimicrobial activity at the N-terminus
  43. Towards the rational design of antimicrobial proteins
  44. Two Human Host Defense Ribonucleases against Mycobacteria, the Eosinophil Cationic Protein (RNase 3) and RNase 7
  45. Exploring New Biological Functions of Amyloids: Bacteria Cell Agglutination Mediated by Host Protein Aggregation
  46. Evolutionary selection for protein aggregation
  47. The “CPC Clip Motif”: A Conserved Structural Signature for Heparin-Binding Proteins
  48. Discovering New In Silico Tools for Antimicrobial Peptide Prediction
  49. Antimicrobial Peptide Action on Parasites
  50. Antimicrobial Action and Cell Agglutination by the Eosinophil Cationic Protein Are Modulated by the Cell Wall Lipopolysaccharide Structure
  51. Structural determinants of the eosinophil cationic protein antimicrobial activity
  52. Lipopolysaccharide Neutralization by Antimicrobial Peptides: A Gambit in the Innate Host Defense Strategy
  53. AMPA: an automated web server for prediction of protein antimicrobial regions
  54. The Generation of Antimicrobial Peptide Activity: A Trade-off between Charge and Aggregation?
  55. The Generation of Antimicrobial Peptide Activity: A Trade-off between Charge and Aggregation?
  56. Refining the Eosinophil Cationic Protein Antibacterial Pharmacophore by Rational Structure Minimization
  57. The role of Gram-negative envelope LPS on the bactericidal properties of proteins and peptides: the case of eosinophil cationic protein
  58. Towards the rational design of antimicrobial peptides: Recent developments in computational tools
  59. Connecting Peptide Physicochemical and Antimicrobial Properties by a Rational Prediction Model
  60. Mapping the eosinophil cationic protein antimicrobial activity by chemical and enzymatic cleavage
  61. Eosinophil Cationic Protein Aggregation: Identification of an N-Terminus Amyloid Prone Region
  62. Eosinophil cationic protein (ECP) can bind heparin and other glycosaminoglycans through its RNase active site
  63. Comparison of human RNase 3 and RNase 7 bactericidal action at the Gram-negative and Gram-positive bacterial cell wall
  64. Bactericidal and membrane disruption activities of the eosinophil cationic protein are largely retained in an N-terminal fragment
  65. Comparison of the membrane interaction mechanism of two antimicrobial RNases: RNase 3/ECP and RNase 7
  66. A theoretical approach to spot active regions in antimicrobial proteins
  67. The Antipathogen Activities of Eosinophil Cationic Protein
  68. Eosinophil Cationic Protein High-Affinity Binding to Bacteria-Wall Lipopolysaccharides and Peptidoglycans†
  69. Topography Studies on the Membrane Interaction Mechanism of the Eosinophil Cationic Protein †